HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hillhouse Capital Related

473.358

+1.9750.42%

Number of Gainers:30

Number of Losers:18

Number of Flat:7

PE:- -

High:480.368

Open:471.419

Low:469.310

Close:471.383

Loading ...

Innovent Biologics Inc. Publishes 2024 Annual Report

Jinke Smart Services Updates On Acquisition Of 18.05% Shareholding In Co By Offeror

Jinke Smart Services - Updates on Acquisition of 18.05% Shareholding in Co by Offeror

THOMSON REUTERS

Jinke Smart Services - on 30 March Offeror Won Auction at Aggregate Bid Price of RMB666.8 Mln

THOMSON REUTERS

Jinke Smart Services - Application Made by Co to Stock Exchange for Resumption of Trading in Shares W.e.f 29 April

THOMSON REUTERS

WuXi AppTec's Q1 Profit Balloons 89%

MT Newswires Live

Hansoh Pharmaceutical Group Co. Ltd. Publishes 2024 Annual Report

Hansoh Pharmaceutical Group Co. Ltd. Releases Environmental, Social and Governance Report

Frontage Narrows Q1 Loss

MT Newswires Live

Genscript Biotech - Unit to Buy 300.0 Mln Series a Preferred Shares of Probio Cayman in Aggregate for US$225.1 Mln

THOMSON REUTERS

WuXi AppTec: Maintains Full-Year Guidance Set at Beginning of Year

THOMSON REUTERS

Junshi Biosciences Gets Registration Certificate in China for 12th Indication of Melanoma Drug

MT Newswires Live

Hansoh Pharmaceutical Gets China Nod to Register Vulvovaginal Candidiasis Drug

MT Newswires Live

Bestzyme's Mellia™ Brazzein Receives FDA "No Questions" Letter, Bringing Creative Sugar Reduction Solution to Global Market

THOMSON REUTERS

Innovent Announces Nmpa Approval of Limertinib, a Third-Generation Egfr Tki Collaborated With Ask Pharma, for the First-Line Treatment of Lung Cancer

THOMSON REUTERS

BRIEF-Zylox-Tonbridge Medical Technology Recommends Distribution Of Final Dividend Of RMB0.1 Per Share

BRIEF-Innovent Biologics Says Third-Generation EGFR TKI Limertinib Received Approval From NMPA

BRIEF-Zylox-Tonbridge Medical Technology Says Intention To Conduct On-Market Share Repurchase

BRIEF-Hansoh Pharmaceutical Receives Drug Registration Approval Of Hengmeida- (Ibrexafungerp Tablets)

Zylox-Tonbridge Medical Technology - Recommends Distribution of Final Dividend of RMB0.1 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1583/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":473.35806,"timestamp":1746000495834,"preClose":471.3829,"halted":0,"volume":449463537,"delay":0,"changeRate":0.00419,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":1.975159,"latestTime":"04-30 16:00:00","open":471.41876,"high":480.36774,"low":469.31015,"amount":12553014206,"amplitude":0.023458,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746149400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745976600000,1745985600000],[1745989200000,1746000000000]],"pbRate":2.238051,"peRate":21.705564,"turnoverRate":0.003086,"increases":30,"decrements":22,"flats":2,"marketCap":2669831540224,"floatMarketCap":2093905376768},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":480.36774,"amplitude":0.023458,"preClose":471.3829,"low":469.31015,"pbRate":"2.238051","latestPrice":473.35806,"volume":449463537,"delay":0,"open":471.41876,"prevYearClose":446.93042,"prevWeekClose":466.075,"prevMonthClose":473.358,"prevQuarterClose":505.776,"fiveDayClose":474.384,"twentyDayClose":512.397,"sixtyDayClose":448.401,"secType":"PLATE","market":"HK","turnoverRate":0.003086,"peRate":21.705564,"marketCap":2669831540224,"floatMarketCap":2093905376768,"timestamp":1746000495834,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":30,"down":18,"flat":7},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531529321","title":"Innovent Biologics Inc. Publishes 2024 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2531529321","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531529321?lang=en_us&edition=fundamental","pubTime":"2025-04-29 06:07","pubTimestamp":1745878048,"startTime":"0","endTime":"0","summary":"Innovent Biologics Inc., a leading biopharmaceutical company, released its 2024 Annual Report, highlighting significant business updates and financial performance. The company reported a 51.8% increase in revenue, reaching RMB 9,421,888,000, and a gross profit of RMB 7,911,678,000, marking a 56.1% rise compared to the previous year. Innovent achieved profitability with a loss reduction of 90.8% year-over-year, posting a loss of RMB 94,631,000 for the year. Notably, the company recorded a Non-IFRS profit of RMB 331,611,000, a turnaround from the previous year's loss. The year 2024 marked historic milestones for Innovent, with record-high revenue and an expanded product portfolio of 15 approved products. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nNDL93M50F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","01911","LU2328871848.SGD","01801","BK1147","LU1969619763.USD","BK1589","LU2488822045.USD"],"gpt_icon":0},{"id":"2530923164","title":"Jinke Smart Services Updates On Acquisition Of 18.05% Shareholding In Co By Offeror","url":"https://stock-news.laohu8.com/highlight/detail?id=2530923164","media":"Reuters","labels":["shareholding","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530923164?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:48","pubTimestamp":1745855323,"startTime":"0","endTime":"0","summary":"April 28 (Reuters) - Jinke Smart Services Group Co Ltd <9666.HK>::*ON 30 MARCH OFFEROR WON AUCTION AT AGGREGATE BID PRICE OF RMB666.8 MILLION*APPLICATION MADE BY CO TO STOCK EXCHANGE FOR RESUMPTION OF","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nRSD1C84Gm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0273","BK1542","BK1229","BK0028","BK1258","BK0174","BK1583","000656","09666","BK0188"],"gpt_icon":0},{"id":"2530888982","title":"Jinke Smart Services - Updates on Acquisition of 18.05% Shareholding in Co by Offeror","url":"https://stock-news.laohu8.com/highlight/detail?id=2530888982","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530888982?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:04","pubTimestamp":1745845477,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R62BV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1542","09666","BK1229","BK1258"],"gpt_icon":0},{"id":"2530400769","title":"Jinke Smart Services  -  on 30 March Offeror Won Auction at Aggregate Bid Price of RMB666.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2530400769","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530400769?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:04","pubTimestamp":1745845477,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R62BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1258","BK1542","BK1229","09666","BK1583"],"gpt_icon":0},{"id":"2530007374","title":"Jinke Smart Services - Application Made by Co to Stock Exchange for Resumption of Trading in Shares W.e.f 29 April","url":"https://stock-news.laohu8.com/highlight/detail?id=2530007374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530007374?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:04","pubTimestamp":1745845477,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R62BV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09666","BK1258","BK1229","BK1583","BK1542"],"gpt_icon":0},{"id":"2530407675","title":"WuXi AppTec's Q1 Profit Balloons 89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530407675","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530407675?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:53","pubTimestamp":1745844835,"startTime":"0","endTime":"0","summary":"WuXi AppTec  recorded an 89% rise in attributable profit in the first quarter to 3.67 billion yuan from 1.94 billion yuan a year prior, a Monday filing with the Hong Kong bourse said.Earnings per share stood at 1.28 yuan in the three months, up from 0.66 yuan in the year-ago period.The drug research and development company's revenue rose 21% to 9.65 billion yuan from 7.98 billion yuan previously.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0456842615.SGD","BK1583","603259","02359","LU2495084118.USD","BK1576","LU0320764599.SGD","LU1997245177.USD","LU2488822045.USD","LU1046422090.SGD","LU2125910500.SGD","BK1141","LU2045819591.USD","BK0216","LU1997244956.HKD","LU0052750758.USD","LU1997245094.SGD","LU2242644610.SGD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2530407101","title":"Hansoh Pharmaceutical Group Co. Ltd. Publishes 2024 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2530407101","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530407101?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:47","pubTimestamp":1745844423,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansoh Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief on April 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nNDL35PFtb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1589","BK1583"],"gpt_icon":0},{"id":"2530071284","title":"Hansoh Pharmaceutical Group Co. Ltd. Releases Environmental, Social and Governance Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2530071284","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530071284?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:46","pubTimestamp":1745844387,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Co. Ltd. published its 2024 Environmental, Social and Governance Report. The report highlights several initiatives and achievements, including eight new innovative drug candidates entering clinical stage, with two in-licensing drug candidates. A self-developed B7-H3 targeting antibody-drug conjugate received Breakthrough Therapy Designation in China, the United States, and Europe. XINYUE  was granted priority review for a new indication for the treatment of IgG4-related diseases. Hansoh Pharma also entered into a License-out agreement with MSD, granting MSD exclusive global license for oral GLP-1 receptor agonist HS-10535 under development. The full report can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as finan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nNDL8FDVjd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","03692","BK1589"],"gpt_icon":0},{"id":"2530098984","title":"Frontage Narrows Q1 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2530098984","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530098984?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:14","pubTimestamp":1745842470,"startTime":"0","endTime":"0","summary":"Frontage (HKG:1521) recorded a net loss of around $900,000 in the first quarter of 2025, narrower than $1 million a year prior, a Monday Hong Kong bourse filing said.Revenue for the biotech firm fell 11% year over year to $57.1 million in the three months from $63.9 million in the year-ago period.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01521","BK1583","BK1576","BK1141"],"gpt_icon":0},{"id":"2530954471","title":"Genscript Biotech - Unit to Buy 300.0 Mln Series a Preferred Shares of Probio Cayman in Aggregate for US$225.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2530954471","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530954471?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:03","pubTimestamp":1745838223,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R60TR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1576","HK0000306685.HKD","HK0000306701.USD","BK1141","HK0000320223.HKD","HK0000320264.USD","BK1583","01548"],"gpt_icon":0},{"id":"2530221264","title":"WuXi AppTec:  Maintains Full-Year Guidance Set at Beginning of Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2530221264","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530221264?lang=en_us&edition=fundamental","pubTime":"2025-04-28 17:34","pubTimestamp":1745832843,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nTUA7NZBB5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1997244956.HKD","02359","LU2045819591.USD","BK1576","LU1997245177.USD","LU0708995583.HKD","LU0052750758.USD","LU0320764599.SGD","603259","BK0216","LU1046422090.SGD","LU2125910500.SGD","LU2495084118.USD","LU0456842615.SGD","LU2242644610.SGD","BK1583","LU1997245094.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2530445003","title":"Junshi Biosciences Gets Registration Certificate in China for 12th Indication of Melanoma Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2530445003","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530445003?lang=en_us&edition=fundamental","pubTime":"2025-04-28 14:54","pubTimestamp":1745823275,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences  received a Drug Registration Certificate for toripalimab after China's National Medical Products Administration approved a supplemental new drug application.The approval comes for the use of the drug as the first-line treatment for unresectable or metastatic melanoma, an April 25 Hong Kong bourse filing said.This marks the approval of toripalimab's 12th indication in the Chinese mainland.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688180","BK1161","BK0239","BK1515","BK1583","01877"],"gpt_icon":0},{"id":"2530644377","title":"Hansoh Pharmaceutical Gets China Nod to Register Vulvovaginal Candidiasis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2530644377","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530644377?lang=en_us&edition=fundamental","pubTime":"2025-04-28 14:37","pubTimestamp":1745822238,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group  has obtained drug registration approval for Hengmeida  from China's National Medical Products Administration, an April 25 Hong Kong bourse filing said.The approval is for use of the drug to treat vulvovaginal candidiasis in adult and post menarche adolescent women.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1583","BK1589","03692"],"gpt_icon":0},{"id":"2530788106","title":"Bestzyme's Mellia™ Brazzein Receives FDA \"No Questions\" Letter, Bringing Creative Sugar Reduction Solution to Global Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2530788106","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530788106?lang=en_us&edition=fundamental","pubTime":"2025-04-27 09:40","pubTimestamp":1745718032,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250427:nTUA3YXQCQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000306685.HKD","HK0000320223.HKD","BK1576","01548","HK0000320264.USD","BK1583","HK0000306701.USD","BK1141"],"gpt_icon":0},{"id":"2530978951","title":"Innovent Announces Nmpa Approval of Limertinib, a Third-Generation Egfr Tki Collaborated With Ask Pharma, for the First-Line Treatment of Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2530978951","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530978951?lang=en_us&edition=fundamental","pubTime":"2025-04-26 08:00","pubTimestamp":1745625603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250426:nTUA3RXWQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01801","BK1589","BK1583","LU2328871848.SGD","LU2488822045.USD","LU1969619763.USD"],"gpt_icon":0},{"id":"2530315229","title":"BRIEF-Zylox-Tonbridge Medical Technology Recommends Distribution Of Final Dividend Of RMB0.1 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2530315229","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530315229?lang=en_us&edition=fundamental","pubTime":"2025-04-26 00:31","pubTimestamp":1745598679,"startTime":"0","endTime":"0","summary":"BRIEF-Zylox-Tonbridge Medical Technology Recommends Distribution Of Final Dividend Of RMB0.1 Per ShareApril 25  - Zylox-Tonbridge Medical Technology Co Ltd 2190.HK:RECOMMENDS DISTRIBUTION OF FINAL DIVIDEND OF RMB0.1 PER SHAREFurther company coverage: 2190.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R30D7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1587","BK1100","02190","BK1583"],"gpt_icon":0},{"id":"2530537151","title":"BRIEF-Innovent Biologics Says Third-Generation EGFR TKI Limertinib Received Approval From NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2530537151","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530537151?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:10","pubTimestamp":1745593806,"startTime":"0","endTime":"0","summary":"BRIEF-Innovent Biologics Says Third-Generation EGFR TKI Limertinib Received Approval From NMPAApril 25 (Reuters) - Innovent Biologics Inc 1801.HK:THIRD-GENERATION EGFR TKI LIMERTINIB RECEIVED APPROVAL FROM NMPAFurther company coverage: 1801.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R31PI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1583","LU2328871848.SGD","01801","BK1161","LU1969619763.USD","BK1589"],"gpt_icon":0},{"id":"2530539391","title":"BRIEF-Zylox-Tonbridge Medical Technology Says Intention To Conduct On-Market Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2530539391","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530539391?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:02","pubTimestamp":1745593348,"startTime":"0","endTime":"0","summary":"BRIEF-Zylox-Tonbridge Medical Technology Says Intention To Conduct On-Market Share RepurchaseApril 25  - Zylox-Tonbridge Medical Technology Co Ltd 2190.HK:INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE TO AMOUNT NOT EXCEEDING HKD650 MILLIONFurther company coverage: 2190.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R30TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02190","BK1587","BK1583","BK1574"],"gpt_icon":0},{"id":"2530320153","title":"BRIEF-Hansoh Pharmaceutical Receives Drug Registration Approval Of Hengmeida- (Ibrexafungerp Tablets)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530320153","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530320153?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:00","pubTimestamp":1745593219,"startTime":"0","endTime":"0","summary":"BRIEF-Hansoh Pharmaceutical Receives Drug Registration Approval Of Hengmeida- April 25  - Hansoh Pharmaceutical Group Company Ltd 3692.HK:DRUG REGISTRATION APPROVAL OF HENGMEIDA-  WAS GRANTED BY NMPAFurther company coverage: 3692.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R30DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","03692","BK1583","BK1191"],"gpt_icon":0},{"id":"2530133070","title":"Zylox-Tonbridge Medical Technology -  Recommends Distribution of Final Dividend of RMB0.1 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2530133070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530133070?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:04","pubTimestamp":1745586270,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nFWN3R30D7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02190","BK1583","BK1100","BK1587","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":72,"code":"91000000","status":"200"}]}}